OppenheimerFunds’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

OppenheimerFunds’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-733,609	Closed	-$6.6M	–	1767
2016 Q2	$6.6M	Sell	733,609 -334,478	-31%	-$3.28M	0.01%	774
2016 Q1	$10.6M	Sell	1,068,087 -880	-0.1%	-$9.03K	0.01%	712
2015 Q4	$12.3M	Buy	1,068,967 +5,440	+0.5%	+$67.3K	0.02%	698
2015 Q3	$14.4M	Hold	1,063,527	–	–	0.02%	641
2015 Q2	$14.7M	Buy	1,063,527 +438,910	+70%	+$5.94M	0.02%	663
2015 Q1	$8.79M	Buy	624,617 +108,390	+21%	+$1.48M	0.01%	777
2014 Q4	$7.03M	Hold	516,227	–	–	0.01%	800
2014 Q3	$7.88M	Buy	516,227 +88,910	+21%	+$1.36M	0.01%	790
2014 Q2	$7.19M	Buy	427,317 +163,090	+62%	+$2.94M	0.01%	814
2014 Q1	$5.3M	Buy	+264,227	New	+$5.72M	0.01%	835

Other funds holding OXFD

Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

OppenheimerFunds's OXFD Position: Q3 2016 in Review

OppenheimerFunds sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q3 2016, closing a stake of 733,609 shares — an estimated $6.6M sold.

OppenheimerFunds first reported a position in OXFD in Q1 2014 and held it in 10 quarters. The position peaked at $14.7M in Q2 2015. 62 funds tracked by Wall St. Rank hold OXFD as of Q3 2016.

OppenheimerFunds reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q3 2016 after selling out during the quarter.
OppenheimerFunds sold 733,609 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2016, an estimated $6.6M.
OppenheimerFunds first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2014 and held it in 10 quarters.
OppenheimerFunds's Oxford Immunotec Global PLC Ordinary Shares position peaked at $14.7M in Q2 2015.
62 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2016.

Based on OppenheimerFunds's 13F filing for Q3 2016, filed 14 Nov 2016.